{"ok":true,"trend":{"id":451044,"platform":"news","region":"global","key":"beyond semaglutide and tirzepatide: the next wave of obesity medicines","title":"Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines","url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYWFDc09fX3p4cGZsNTFyczVMZXpwU3JBYy16THBkc2dHbEFOaUFTZUE5NnlmczM0Y0twMWpwek9Kb0dPb2s3T19GMEM0cXA5NVpka3BJWHB5SHdoeXFpWmpicDctbmFTVDN6TkJaVVJjLXBiZDRJelBGRE84LU9XODgzVlRXQVFTT0ZLMjNhWGRzOFl1NUgxcjgzeXpWeVoyWTFTdkJITU9nczJS?oc=5","first_seen":"2026-09-30T06:22:52.532462Z","last_seen":"2026-09-30T06:22:52.532462Z","last_rank":34,"peak_rank":34,"last_volume":null,"peak_volume":null,"seen_count":1,"score":0.6071875,"category_hint":"medicine","section":"health","category":"medicine","summary":"A new wave of obesity medicines is being discussed as the field looks beyond the established GLP-1 drugs semaglutide and tirzepatide. Coverage highlights emerging treatments in development that could expand options for patients and clinicians treating obesity, a category that has drawn enormous attention since GLP-1 therapies reshaped weight-loss care. Details on specific drug candidates remain limited.","why":"Ongoing high interest in obesity treatments as newer weight-loss drugs move through development","tone":"neutral","entities":["semaglutide","tirzepatide"],"summarized_at":"2026-09-30T06:23:11.846204Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Patient Care Online","published":"Wed, 30 Sep 2026 01:08:27 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"The Next Wave of Obesity Medicines Beyond Semaglutide and Tirzepatide","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-30T06:22:52.532462Z","rank":34,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYWFDc09fX3p4cGZsNTFyczVMZXpwU3JBYy16THBkc2dHbEFOaUFTZUE5NnlmczM0Y0twMWpwek9Kb0dPb2s3T19GMEM0cXA5NVpka3BJWHB5SHdoeXFpWmpicDctbmFTVDN6TkJaVVJjLXBiZDRJelBGRE84LU9XODgzVlRXQVFTT0ZLMjNhWGRzOFl1NUgxcjgzeXpWeVoyWTFTdkJITU9nczJS?oc=5","author":"Patient Care Online","title":"Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines","snippet":null,"posted_at":"2026-09-30T01:08:27Z","likes":null}],"elsewhere":[],"window":"7d"}}